Literature DB >> 10068469

Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus.

P A Hoodless1, T Tsukazaki, S Nishimatsu, L Attisano, J L Wrana, G H Thomsen.   

Abstract

Smads are central mediators of signal transduction for the TGFbeta superfamily. However, the precise functions of Smad-mediated signaling pathways in early development are unclear. Here we demonstrate a requirement for Smad2 signaling in dorsoanterior axis formation during Xenopus development. Using two point mutations of Smad2 previously identified in colorectal carcinomas, we show that Smad2 ushers Smad4 to the nucleus to form a transcriptional activation complex with the nuclear DNA-binding protein FAST-1 and that the mutant proteins interact normally with FAST-1 but fail to recruit Smad4 into the nucleus. This mechanism of inhibition specifically restricts the dominant-negative activity of these mutants to the activin/Vg1 signaling pathway without inhibiting BMPs. Furthermore, expression of these mutants in Xenopus animal caps inhibits but does not abolish activin and Vg1 induction of mesoderm and in the embryo results in a truncated dorsoanterior axis. These studies define a mechanism through which mutations in Smad2 may block TGFbeta-dependent signaling and suggest a critical role for inductive signaling mediated by the Smad2 pathway in Xenopus organizer function. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068469     DOI: 10.1006/dbio.1998.9168

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  23 in total

1.  Activin receptor patterning of foregut organogenesis.

Authors:  S K Kim; M Hebrok; E Li; S P Oh; H Schrewe; E B Harmon; J S Lee; D A Melton
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  FoxH1 (Fast) functions to specify the anterior primitive streak in the mouse.

Authors:  P A Hoodless; M Pye; C Chazaud; E Labbé; L Attisano; J Rossant; J L Wrana
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

3.  Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling.

Authors:  K Shimizu; P Y Bourillot; S J Nielsen; A M Zorn; J B Gurdon
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  HEB and E2A function as SMAD/FOXH1 cofactors.

Authors:  Se-Jin Yoon; Andrea E Wills; Edward Chuong; Rakhi Gupta; Julie C Baker
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

5.  Transcriptional integration of Wnt and Nodal pathways in establishment of the Spemann organizer.

Authors:  Christine D Reid; Yan Zhang; Michael D Sheets; Daniel S Kessler
Journal:  Dev Biol       Date:  2012-05-22       Impact factor: 3.582

6.  Opposing Nodal/Vg1 and BMP signals mediate axial patterning in embryos of the basal chordate amphioxus.

Authors:  Takayuki Onai; Jr-Kai Yu; Ira L Blitz; Ken W Y Cho; Linda Z Holland
Journal:  Dev Biol       Date:  2010-05-19       Impact factor: 3.582

7.  Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.

Authors:  Bryan M Zhao; F Michael Hoffmann
Journal:  Mol Biol Cell       Date:  2006-06-14       Impact factor: 4.138

8.  FoxH1 mediates a Grg4 and Smad2 dependent transcriptional switch in Nodal signaling during Xenopus mesoderm development.

Authors:  Christine D Reid; Aaron B Steiner; Sergey Yaklichkin; Qun Lu; Shouwen Wang; Morgan Hennessy; Daniel S Kessler
Journal:  Dev Biol       Date:  2016-04-13       Impact factor: 3.582

Review 9.  Regulation of Smad activities.

Authors:  Lan Xu
Journal:  Biochim Biophys Acta       Date:  2006-11-15

10.  Activin signaling: effects on body composition and mitochondrial energy metabolism.

Authors:  Liunan Li; Joseph J Shen; Juan C Bournat; Lihua Huang; Abanti Chattopadhyay; Zhihong Li; Chad Shaw; Brett H Graham; Chester W Brown
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.